Skin phosphorylated tau was recently found to be elevated in manifest HD compared with premanifest HD and healthy controls and correlated with CAG repeat length, CAP score, motor function clinical scores, and neuroimaging data. This evidence concerns the gene MAPT and Huntington disease.